Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

@article{Behrens2000LipodystrophySI,
  title={Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?},
  author={Georg M N Behrens and Matthias Stoll and Reinhold Ernst Schmidt},
  journal={Drug safety},
  year={2000},
  volume={23 1},
  pages={57-76}
}
Since the introduction of HIV-1 protease inhibitors as components of antiretroviral drug combination regimens, the clinical course of HIV disease and opportunistic infections has changed dramatically. Besides the favourable virological, immunological and clinical impact of highly active antiretroviral therapy (HAART), several adverse drug reactions have… CONTINUE READING